MALDI mass spectrometry
BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System
The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US.
Agilent Q3 Revenues Up 6 Percent
The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.
Biodesix, MRM Proteomics Partner on Lung Cancer Assays
Under the agreement, MRM Proteomics has granted Biodesix rights to use its iMALDI mass spectrometry technologies to develop blood-based tests for lung cancer.
Bruker Receives FDA Approval for Expanded MALDI Biotyper
The new version of the mass spectrometry-based system adds 144 microbial species to its database and includes new tools for sample preparation.
With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms.
May 11, 2016
Apr 8, 2016
Feb 25, 2016
At MSACL 2016, Extra Attention on Mass Spec-Based Dx
Jul 22, 2011
Apr 8, 2011